gms | German Medical Science

68. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)
7. Joint Meeting mit der Britischen Gesellschaft für Neurochirurgie (SBNS)

Deutsche Gesellschaft für Neurochirurgie (DGNC) e. V.

14. - 17. Mai 2017, Magdeburg

Dual-labelling with ALA and fluorescein for fluorescence-guided resection of high-grade gliomas – technical report

Meeting Abstract

  • Eric Jose Suero Molina - Universitätsklinikum Münster, Klinik und Poliklinik für Neurochirurgie, Münster, Deutschland
  • Johannes Wölfer - Klinik und Poliklinik für Neurochirurgie, Universitätsklinikum Münster, Münster, Deutschland
  • Christian Ewelt - Klinik für Neurochirurgie, Universitätsklinik Münster, Münster, Deutschland
  • Andre Ehrhardt - Karl Storz GmbH & Co., Tuttlingen, Deutschland
  • Benjamin Brokinkel - Klinik und Poliklinik für Neurochirurgie, Universitätsklinikum Münster, Münster, Deutschland
  • Walter Stummer - Universitätsklinikum Münster, Klinik und Poliklinik für Neurochirurgie, Münster, Deutschland

Deutsche Gesellschaft für Neurochirurgie. Society of British Neurological Surgeons. 68. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC), 7. Joint Meeting mit der Society of British Neurological Surgeons (SBNS). Magdeburg, 14.-17.05.2017. Düsseldorf: German Medical Science GMS Publishing House; 2017. DocMO.22.04

doi: 10.3205/17dgnc131, urn:nbn:de:0183-17dgnc1319

Veröffentlicht: 9. Juni 2017

© 2017 Suero Molina et al.
Dieser Artikel ist ein Open-Access-Artikel und steht unter den Lizenzbedingungen der Creative Commons Attribution 4.0 License (Namensnennung). Lizenz-Angaben siehe http://creativecommons.org/licenses/by/4.0/.


Gliederung

Text

Objective: Fluorescence-guidance with 5-ALA helps improve resections of malignant gliomas. However, one limitation is the low intensity of blue light for background illumination. Fluorescein has recently been re-introduced into neurosurgery and novel microscope systems are available for visualizing this fluorochrome, which highlights all perfused tissues but has limited selectivity for tumor detection. We here investigate a combination of both fluorochromes, ALA for distinguishing tumor and fluorescein for providing tissue fluorescence of adjacent brain tissue.

Methods: We evaluated six patients with cerebral lesions suggestive of high-grade glioma. Patients received ALA (20mg/kg) orally four hours before induction of anesthesia. Low dose fluorescein (3mg/kg i.v.) was injected immediately after anesthesia induction. Zeiss Pentero microscopes (equipped either with Yellow560 or Blue400 filters) were used to visualize fluorescence. To simultaneously visualize both fluorochromes, the Yellow560 module was combined with external blue light illumination (Storz D-Light).

Results: Fluorescein-induced fluorescence created a useful background for protoporphyrin IX (PPIX) fluorescence, which appeared orange to red, surrounded by greenly fluorescent normal brain and edematous tissue. Green brain tissue fluorescence was helpful in augmenting background. Too strong levels of blue illumination obscured PPIX fluorescence. Unspecific extravasation of fluorescein was noted at resection margins, which did not interfere with PPIX fluorescence detection.

Conclusion: Dual labeling with both PPIX and fluorescein fluorescence is feasible and gives superior background information during fluorescence guided-resections. We believe this technique carries potential as a next step in fluorescence-guided resections if completely integrated into the surgical microscope.